1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study
(
- Contribution to journal › Article
-
Mark
Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
(
- Contribution to journal › Article
-
Mark
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
(
- Contribution to journal › Article
- 2023
-
Mark
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2022
-
Mark
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations
(
- Contribution to journal › Article
-
Mark
Mer-tyrosine kinase : a novel susceptibility gene for SLE related end-stage renal disease
(
- Contribution to journal › Article
-
Mark
Complement C4 copy number variation is linked to SSA/Ro and SSB/La autoantibodies in systemic inflammatory autoimmune diseases
(
- Contribution to journal › Article
- 2021
-
Mark
Quick Systemic Lupus Activity Questionnaire (Q-SLAQ) : A simplified version of SLAQ for patient-reported disease activity
(
- Contribution to journal › Article
-
Mark
C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
(
- Contribution to journal › Article